Immunoglobulin G1 (human Fc Fragment) Fusion Protein With Peptide (synthetic 17-amino Acid Linker) Fusion Protein With Adnectin Uses, Dosage, Side Effects and more
Immunoglobulin G1 (human Fc Fragment) Fusion Protein With Peptide (synthetic 17-amino Acid Linker) Fusion Protein With Adnectin is under investigation in clinical trial NCT03039686 (Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy).
| Trade Name | Immunoglobulin G1 (human Fc Fragment) Fusion Protein With Peptide (synthetic 17-amino Acid Linker) Fusion Protein With Adnectin |
| Generic | Talditercept alfa |
| Talditercept alfa Other Names | Adnectin, anti-(human growth differentiation factor 8) (synthetic clone prd-1474 fibronectin type iii tenth domain (10fn3)-based isoform, Bms-986089 (fully human anti-myostatin adnectin), Immunoglobulin g1 (human fc fragment) fusion protein with peptide (synthetic 17-amino acid linker) fusion protein with adnectin, anti-(human growth differentiation factor 8) (human clone bms-986089 fibronectin tenth type iii domain-derived), dimer, Taldefgrobep alfa, Talditercept alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
